| Kelli Hursh, DPT | |
|
3313 Chili Ave, Rochester, NY 14624-5300 | |
| (585) 889-7777 | |
| (585) 889-8282 |
| Full Name | Kelli Hursh |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 3313 Chili Ave, Rochester, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275508459 | NPI | - | NPPES |
| 47965337 | Other | AETNA | |
| 125745FT | Other | NY | PREFERRED CARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 025750 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelli Hursh, DPT 92 West Ave, Brockport, NY 14420-1306 Ph: (585) 637-0790 | Kelli Hursh, DPT 3313 Chili Ave, Rochester, NY 14624-5300 Ph: (585) 889-7777 |
News Archive
One traditional approach to pharmaceutical design uses so-called "first messengers" – hormones, other natural facilitators or synthetic products – to initiate various cellular cascades for the desired physiological effect. To date, despite concerted efforts at all levels of research, this approach has failed to develop a truly successful obesity drug to address this major global health problem.
Nova Biomedical simplifies critical care testing with Stat Profile Prime®, a new blood gas analyzer that combines the revolutionary micro-electronics of the consumer world with Nova's innovative ZERØ™ maintenance cartridge technology for a smaller, faster, and less expensive critical care analyzer.
Sangamo BioSciences, Inc. announced today the presentation of preliminary data from the Phase 2 clinical trial of its ZFP Therapeutic(TM) program to develop SB-509 as a treatment for amyotrophic lateral sclerosis (ALS) at a Work in Progress session at the 20th International Symposium on ALS/MND held in Berlin, Germany.
Neutra Corp., an emerging nutraceuticals provider, is pleased to announce that clinical trials are now underway on its new and improved weight-loss supplement, Pure Plus Weight Loss.
Oraya® Therapeutics, Inc. announced today that initial three-year safety follow-up data from its INTREPID study of Oraya Therapy™ stereotactic radiotherapy for the treatment of wet age-related macular degeneration (AMD) were presented for the first time today during the America Academy of Ophthalmology's (AAO) annual meeting in New Orleans.
› Verified 8 days ago
Carrie Marie Nicholas, Physical Therapist Medicare: Medicare Enrolled Practice Location: 3399 Winton Rd S, Rochester, NY 14623 Phone: 585-334-6000 | |
Hannah Steiner Becker, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Elmwood Ave, Suite 100, Rochester, NY 14620 Phone: 585-271-0761 | |
Jacob Resnick, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 515 Long Pond Rd, Rochester, NY 14612 Phone: 585-227-2310 Fax: 585-227-2312 | |
Laura Jean Mcgowan, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 620 Westfall Rd, Rochester, NY 14620 Phone: 585-461-8500 | |
Shelby Hutton, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1000 Elmwood Ave Ste 400, Rochester, NY 14620 Phone: 585-271-0680 | |
Lattimore Physical Therapy Physical Therapist Medicare: Medicare Enrolled Practice Location: 383 White Spruce Blvd, Rochester, NY 14623 Phone: 585-442-6067 Fax: 585-442-6073 | |
Mrs. Shannon N Schiller, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 120 Erie Canal Dr, Suite 310, Rochester, NY 14626 Phone: 585-225-6296 Fax: 585-225-2839 |